All modern advances notwithstanding, pneumonia remains a common infection with
substantial morbidity and mortality. Understanding of the etiology of pneumonia continues to …

Respiratory tract infections (RTIs) are the focus of developments in public health, given their
widespread distribution and the high morbidity and mortality rates reported worldwide. The …

The pandemic of coronavirus disease 2019 (COVID-19), due to the novel coronavirus
(SARS-CoV-2), has created an unprecedented threat to the global health system, especially …

International guidelines recommend the initiation of empirical antibiotherapy for possible
associated bacterial pneumonia in COVID-19 critically ill yet further suggesting a rapid …

Antibiotic resistance is recognised as a global threat to human health by national healthcare
agencies, governments and medical societies, as well as the World Health Organization …

Background Rapid and accurate detection of pathogens is needed in community-acquired
pneumonia (CAP) to enable appropriate antibiotics and to slow the development of antibiotic …

Because the diagnosis of co/superinfection in COVID-19 patients is challenging, empirical
antibiotic therapy is frequently initiated until microbiological analysis results. We evaluated …

Lack of rapid and comprehensive microbiological diagnosis in patients with community
acquired pneumonia (CAP) hampers appropriate antimicrobial therapy. This study evaluates …

Background Accuracy and timing of antibiotic therapy remain a challenge for lower
respiratory tract infections. New molecular techniques using Multiplex Polymerase Chain …

Background Culture-based microbiological investigation of hospital-acquired or ventilator-
associated pneumonia (HAP or VAP) is insensitive, with aetiological agents often …